Supreme Court to hear healthcare reform case

Jeff Byers | | Health Exec | EMR/EHR
Supreme Court - 19.06 Kb
The Supreme Court has announced that it plans to review the controversial healthcare reform law that requires minimum healthcare coverage.

Published in the Nov. 14 order list, the federal court granted writ of certiorari for the case of U.S. Department of Health and Human Services v. State of Florida, et al. “The parties are directed to brief and argue [an additional question]: ‘whether the suit brought by respondents to challenge the minimum coverage provision of the Patient Protection and Affordable Care Act is barred by the Anti-Injunction Act,” the order list stated.

In January, Judge Roger Vinson of the Federal District Court in Pensacola, Fla., ruled that PPACA’s individual insurance mandate is unconstitutional and struck down the act in its entirety.

Jeff Byers

Related Content

Academic health system working on AI dictation feature for Epic
Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
PHOTO GALLERY: The Epic intergalactic headquarters art collection
AI brings cardiology, neurology teams together to boost care for stroke patients
Best in KLAS: End-users review top health IT systems in the US
More than words: AI takes NLP to the next level to identify signs of heart failure

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.